Trident Texofab Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 210.29 million compared to INR 156.27 million a year ago. Revenue was INR 212.93 million compared to INR 158.72 million a year ago. Net income was INR 0.157 million compared to net loss of INR 0.212 million a year ago. Basic earnings per share from continuing operations was INR 0.02 compared to basic loss per share from continuing operations of INR 0.02 a year ago. Diluted earnings per share from continuing operations was INR 0.02 compared to diluted loss per share from continuing operations of INR 0.02 a year ago. For the six months, sales was INR 359.34 million compared to INR 168.93 million a year ago. Revenue was INR 363.09 million compared to INR 171.15 million a year ago. Net income was INR 1.69 million compared to net loss of INR 3.57 million a year ago. Basic earnings per share from continuing operations was INR 0.17 compared to basic loss per share from continuing operations of INR 0.35 a year ago. Diluted earnings per share from continuing operations was INR 0.17 compared to diluted loss per share from continuing operations of INR 0.35 a year ago.